Clinical Trial
Published on 21 Nov 2023
Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy
in Immunosuppression

- 1,126 views
- 4 citations